ArticleJournal of cellular and molecular medicine2025
Revealing Putative Causal Genes by Establishing the Causality Between Different Lymphomas and Immune Cells.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tumour immune microenvironment (TIME) is critical for lymphoma progression and therapy resistance, yet causal relationships between specific immune cell types and lymphoma subtypes remain poorly defined. In this study, using bidirectional Mendelian randomization (MR), genetic correlation (LDSC), and expression-QTL integration (SMR), we systematically evaluated causal relationships and genetic correlation between immune cells and various lymphomas. Additionally, we utilised the Mendelian randomization-based method of summary data-based MR (SMR), which incorporated genome-wide association studies (GWAS) and expression quantitative trait loci (eQTL) data from immune cells to identify genes associated with lymphoma. Furthermore, colocalization analysis and genetic correlation analysis were conducted for further validation of our findings. The two-sample mendelian randomization approach was employed to identify the immune cell types that exhibit a causal relationship with different lymphomas. Additionally, the genetic correlation between these immune cells and lymphomas was further analysed using the linked disequilibrium score regression method, thereby enhancing the reliability of our findings. The SMR and colocalisation analyses revealed several genes associated with these immune cells, thereby providing additional support for their putative role in the pathogenesis of lymphoma. Our study elucidates the intricate interplay between immune cells by employing genetic methodologies, thus suggesting novel therapeutic candidates that warrant experimental validation and risk predictors in different subtypes of lymphoma treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.